Evolus, Inc.
EOLS
Rang in aandelen
#12956
Evolus, Inc. is a performance beauty enterprise that furnishes the United... Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
Aandeelprijs
$7.60
Marktkapitalisatie
$501.65M
Verandering (1 dag)
2.64%
Verandering (1 jaar)
-47.91%
Land
US
Handel Evolus, Inc. (EOLS)
Categorie
Healthcare
Koersgeschiedenis voor Evolus, Inc. (EOLS)
Hoogste slotkoers: $12.39 op 2025-01-01
Laagste slotkoers: $19.84 op 2018-08-01
Laagste slotkoers: $19.84 op 2018-08-01
Koersgeschiedenis van Evolus, Inc. van 2018 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2025 | 3.66% |
| 2024 | 20.62% |
| 2023 | 39.40% |
| 2022 | 15.12% |
| 2021 | -56.66% |
| 2019 | -3.72% |
| 2018 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
